Share
Compartir
- Add this to...
- Añadir en...
- Favorites
- Delicious
- Digg
- Google Bookmarks
Flu Season Event: Submit Your Plans
This form is for our Flu Prevention Partners to submit activities and events taking place throughout the 2012-2013 flu season. If your organization has events specific to NIVW, please use the NIVW 2012 activity submission form.
Contact Us:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348 - Contact CDC-INFO
Seasonal Influenza (Flu)
- 2013-2014 Flu Season
- Influenza - Flu Basics
- Prevention - Flu Vaccine
- Take 3 Actions To Fight The Flu
- Key Facts About Seasonal Flu Vaccine
- Vaccine Safety
- Approved Influenza Vaccines
- Who Should Get Vaccinated Against Influenza
- Children, the Flu, and the Flu Vaccine
- Caregivers of Children Less Than 6 Months Old
- Good Health Habits
- Questions & Answers
- 2012-2013 Vaccine Safety
- Antiviral Drug Resistance
- Cell-based Flu Vaccines
- Febrile Seizures
- Flu Shot
- Flublok Seasonal Influenza Vaccination
- Fluzone High-Dose Seasonal Influenza Vaccine
- Guillain-Barré Syndrome (GBS)
- Intradermal Influenza (Flu) Vaccination
- Nasal Spray Vaccine (LAIV)
- Preventing the Flu
- Seasonal Flu Vaccine Safety and Pregnant Women
- Selected Publications
- Thimerosal
- Vaccine Dosage & Administration
- Vaccine Effectiveness
- Vaccine Safety Monitoring Systems
- Vaccine Supply and Distribution in the United States
- Vaccine Supply for 2012-13 Season
- National Influenza Vaccination Week (NIVW)
- Treatment - Antiviral Drugs
- Specific Groups
- Health Professionals
- ACIP Recommendations
- 2013-2014 Interim Vaccination Recommendations
- 2012-13 Vaccination Recommendations
- Introduction and Biology of Influenza
- Options for Controlling Influenza
- Influenza Vaccine Composition
- Major Differences Between TIV and LAIV
- Recommendations for Using TIV and LAIV During the Influenza Season
- Dosage, Administration, and Storage
- Persons for Whom Annual Vaccination is Recommended
- Persons Who Should Not Be Vaccinated
- Vaccination of Specific Populations
- Shedding, Transmission, and Stability of LAIV Viruses
- Influenza Vaccines and Use of Influenza Antiviral Medications
- Concurrent Administration of Influenza Vaccine With Other Vaccines
- Adverse Events After Receipt of TIV
- Adverse Events After Receipt of LAIV
- Timing of Vaccination
- Vaccine Supply Considerations
- Evaluating Vaccine Studies
- Vaccination
- Vaccine Supply Update
- Influenza Vaccination: A Summary for Clinicians
- Seasonal Influenza Vaccine Safety: A Summary for Clinicians
- Selecting the Viruses in the Influenza (Flu) Vaccine
- Large-Scale Influenza Vaccination Clinic Planning
- Flu Vaccine Effectiveness
- Reallocating Influenza Vaccine
- Vaccination Information for Health Care Workers
- Antiviral Drugs
- Influenza Antiviral Medications: Summary for Clinicians
- Antiviral Agents for Influenza
- Antiviral Drug Resistance Among Influenza Viruses
- Use of Antivirals
- Dosage
- Adverse Events
- Drug Interactions
- Emergency Use Authorization
- Specific Populations
- Recommendations for Obstetric Health Care Providers Related to Use of Antiviral Medications
- Additional Links and Resources
- References
- Infection Control
- Prevention Strategies for Seasonal Influenza in Healthcare Settings
- Interim Guidance for Influenza Outbreak Management in Long-Term Care Facilities
- Settings Where High-Risk Persons & Their Contacts May Be Targeted For Vaccination
- Prevention & Control of Influenza in the Peri- and Postpartum Settings
- Interim Guidance for the Use of Masks to Control Influenza Transmission
- Respiratory Hygiene/Cough Etiquette
- Clinical Description & Lab Diagnosis
- Influenza Symptoms and the Role of Laboratory Diagnostics
- Rapid Diagnostic Testing: Information for Health Care Professionals
- Rapid Diagnostic Testing: Information for Clinical Laboratory Directors
- Guidance for Clinicians on the Use of Rapid Influenza Diagnostic Tests
- Guidance for Clinicians on the Use of RT-PCR and Other Molecular Assays for Diagnosis of Influenza Virus Infection
- Clinical Signs and Symptoms of Influenza
- International Influenza
- Training
- References & Resources
- Communications to Health Care Providers
- ACIP Recommendations
- Information For Partners
- Flu Activity & Surveillance
- Situation Update: Summary of Weekly FluView
- Overview of Influenza Surveillance in the United States
- Current United States Flu Activity Map
- Weekly U.S. Influenza Surveillance Report
- FluView Interactive
- Past Weekly Surveillance Reports
- United States Surveillance Data: 1997-1998 through 2005-2006 Seasons
- Estimating Seasonal Influenza-Associated Deaths in the United States
- Staph Infections
- FluVaxView Influenza Vaccination Coverage
- FluVaxView Interactive!
- Vaccination Trends
- 2012-13 Flu Season
- 2011-12 Flu Season
- Flu Vaccination Coverage, United States, 2011-12 Influenza Season
- 2011-12 Flu Season, Interactive Map (Report I)
- 2011-12 Flu Season, Interactive Map (Report II)
- 2011-12 Flu Season, National Immunization Survey and National Flu Survey, March 2012
- 2011-12 Flu Season, National Flu Survey, November 2011
- 2011-12 Flu Season, Health Care Personnel (Internet Panel Survey)
- 2011-12 Flu Season, Pregnant Women (Internet Panel Survey)
- 2010-11 Flu Season
- 2009-10 Flu Season
- 2008-09 and Earlier Flu Seasons
- References, Presentations, & Other Publications
- Quick Links by Population
- News & Highlights
- Avian Flu
- Avian Influenza A (H7N9) Virus
- Basic Information on H7N9
- Health Care and Laboratorian Guidance
- Interim Guidance on the Use of Antiviral Agents for Treatment of Human Infections with Avian Influenza A (H7N9)
- Interim Guidance on Case Definitions to be Used for Novel Influenza A (H7N9) Case Investigations in the United States
- Interim Guidance for Specimen Collection, Processing, and Testing for Patients Who May Be Infected with Avian Influenza A (H7N9) Virus
- Diagnostics for Detecting H7N9 Using rRT-PCR
- Interim Guidance for Infection Control Within Healthcare Settings When Caring for Patients with H7N9
- Interim Risk Assessment and Biosafety Level Recommendations for Working With Influenza A(H7N9) Viruses
- Travelers
- In the News
- Additional Information
- H7N9 Images
- Swine Flu
- Influenza A (H3N2) Variant Virus
- Situation Summary
- Past Updates
- Case Count
- H3N2v and You
- Prevention
- Treatment
- Health Care Providers
- Prevention Strategies for Seasonal and Influenza A(H3N2)v in Health Care Settings
- Interim Information for Clinicians about Human Infections with H3N2v Virus
- Interim Guidance for Enhanced Influenza Surveillance: Additional Specimen Collection for Detection of Influenza A (H3N2) Variant Virus Infections
- Interim Guidance on Specimen Collection, Processing, and Testing for Patients with Suspect Influenza A(H3N2)v Virus Infection
- Interim Guidance on Case Definitions to be Used For Investigations of Influenza A(H3N2)v Virus Cases
- Guidance for Public Health
- Other Guidance Documents
- News & Highlights
- Materials & Resources
- Specific Audiences
- National Influenza Vaccination Week (NIVW)
- Vaccination Pledge
- What's New & Updated!
- Free Resources
- Other Flu Websites



